James Fraser was Appointed as Senior Director, Commercial and Regulatory Counsel at Portola

Date of management change: March 15, 2019 

What Happened?

South San Francisco, CA-based Portola Appointed James Fraser as Senior Director, Commercial and Regulatory Counsel


About the Company

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.


About the Person

James Fraser is Senior Director, Commercial and Regulatory Counsel at Portola. Previously, James held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Davalle Dina, Thomson David, Howard Kevin, Jordan Christy, Kapples Jack, White Cynthia, Erramouspe Matthew, Amidon Daniel, Beasley Michele, Lefton Kevin, Vickery Michelle

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.